Researchers launched a unique collaboration on Wednesday aimed at getting cancer drugs to the market more quickly in which three companies will cooperate with the U.S. government and non-profit groups to test five experimental breast cancer drugs.
The five-year, $26 million study called Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis, or I-SPY2, will aim to use DNA to match the best drug to each patient and to more quickly toss out approaches that do not work or are too toxic.
"They'll get the latest and greatest in terms of targeted drugs," Dr. Anna Barker, deputy director of the National Cancer Institute, said in an interview.
"I think it's the future. Government couldn't have done it on their own and these companies couldn't have done it on their own."
Unusually, the companies agreed to share information on using genes to predict how well a patient will respond as part of the Biomarkers Consortium, which includes the U.S. Food and Drug Administration and the National Institutes of Health.
"I-SPY 2 will provide a path to personalized medicine," said Dr. Laura Esserman, a breast cancer surgeon at the University of California San Francisco who will help lead the clinical trials. "We intend that every drug will graduate with a companion marker."
The trial will match patients to one of five experimental drugs:
-- ABT-888 or veliparib, being developed by Abbott Laboratories. The pill is a PARP inhibitor, which blocks a cell repair enzyme used by cancer cells.
-- AMG 655 or conatumumab, a targeted drug being developed by Amgen. It boosts a protein called APO/TRAIL that causes cancer cells to self-destruct.
-- Amgen's AMG 386, an angiogenesis inhibitor that stops tumors from growing blood vessels to nourish themselves.
-- CP-751,871 or figitumumab, being developed by Pfizer Inc to target the insulin growth factor receptor or IGFR.
-- Pfizer's HKI-272 or neratinib, another targeted therapy called a Pan ErbB inhibitor that targets several related receptors used by cancer cells.
The group is negotiating with other companies to add their experimental drugs to the mix.
"It'll speed up the whole process," Barker said.
The drug company lobby group PhRMA estimates it can take as long as 15 years and cost more than $1.3 billion dollars to take a new drug from laboratory to pharmacy.
Patients at 20 cancer centers will be tested right after they get tiny samples of tissue taken in biopsies. Before they ever get surgery, they will be treated with one of the drugs to see if this helps prevent tumor spread.
Up to 12 different cancer drugs will be tested. Unusually, the group has FDA approval to drop and add drugs throughout the course of the trial without having to stop it to write a whole new protocol.
Turkish environment minister signs historic agreement in New York against taking action against climate change
Human defense mechanisms could be disrupted by the presence of a class of organic pollutants in fish and other food, according to new research.
'The time has come to treat childhood stunting as a development and an economic emergency,' World Bank Group head says
Obese population hits all-time high with a new studying finding that obesity can be predicted in babies
New research factors in collapsing Antarctic ice sheet that could double the sea-level rise to two metres by 2100 if emissions are not cut
Temperatures in the first two months of 2016 followed a year that broke 'all previous records by a wide margin'
Researchers at MIT may have made an important breakthrough in the fight against Alzheimer’s Disease.
Human immune system could be steered towards fighting cancerous tumors, researchers find
Data released on UN world wildlife day shows overall population is still falling despite a recent reduction in levels of poaching for ivory
Google will donate $1mn to help UNICEF map Zika outbreaks
The grounding of an iceberg has forced thousands of penguins to walk more than 60 km to find food
'The level of alarm is extremely high,' says WHO head, calls for an emergency meeting
One person has tested positive in Denmark for the mosquito-borne Zika virus
The world is making 20 times more plastic than we did 50 years ago with the majority being dumped in the sea.
Colombia's government has signed new legislation for the regulation and legalization of cannabis to be used for medicinal purposes.
Scientists predict Earth will become increasingly hostile for mankind as it warms, with disastrous storms, floods and droughts, and rising sea levels that will consume islands and eat away at populated coasts